Innovative. Growing. Diversified.

Committed to You.

Explore Our Products

We Stand By Our Values

 

For seven decades, Mission Pharmacal Company has been improving the lives of families like yours, through every stage of life, with innovative, high-quality products. Our wide range of prescription medications and over-the-counter drug products are produced from superior raw materials. Many are made in U.S.-based manufacturing facilities.

We are recognized as a pioneer and leader in the therapeutic areas of women’s health and urology. Mission also offers other leading products through our pediatric, dermatology, primary care service lines and long-term care service lines.

 

Learn More About Our Company

 

 

 

 

We Stand By Our Product Offerings

 

 

   WOMEN'S HEALTH

Delivers high-quality products for bone health, osteoporosis treatment and prevention, and nutritional supplementation.

   UROLOGY

Offers life-improving medical management options for people with kidney stone disease.

   PEDIATRICS

Provides a full range of prescription and non-prescription solutions for everyday childhood medical conditions.

 

 

   DERMATOLOGY

Helps physicians address chronic and acute dermatological conditions affecting a patient’s quality of life.

 

    PRIMARY CARE

Reaches more physicians, specialists in acute and chronic illnesses and preventative care, as well as their patients with high-quality, innovative healthcare products.

 

    LONG-TERM CARE

Serves the special needs of long-term care patients with unique products providing alternative delivery systems for enhanced convenience and comfort.

   OVER-THE-COUNTER
   PRODUCTS

A wide range of non-prescription solutions that provide comfort, healing, improved performance or relief for patients and consumers.

 

 

 

Learn More About Therapeutic Areas

 

 

We Stand By Our Core Capabilities

 

 

 

Latest News

Mission Pharmacal enters into agreement with MainPointe Pharmaceuticals to purchase and license Mission’s consumer products
SAN ANTONIO (February 21, 2018) – Mission Pharmacal Company (“Mission”) announced today that it has recently divested several consumer products to MainPointe Pharmaceuticals, LLC (“MainPointe”). In addition, the marketing rights of additional consumer products have been licensed by Mission to...
Fabre-Kramer Partners with Mission Pharmacal for Future Commercial Manufacture of Novel Mechanism Antidepressant Travivo™ (Gepirone HCL) Tablets
Houston and San Antonio, TX (January 3, 2018) – Fabre-Kramer Pharmaceuticals, Inc. (Fabre-Kramer) of Houston, TX, and Mission Pharmacal Company (Mission) of San Antonio, TX, announced today that they have signed agreements providing for Mission to complete the technology transfer to develop and...
Alamo Pharma Services announces launch of Alamo Training – a complete provider of training services for the pharma and biotech industry
DOYLESTOWN, Pa. (December 19, 2017) – Peter Marchesini, Chief Operating Officer of Alamo Pharma Services (“Alamo”), participated as one of two panelists in a session at the recent FDA/CMS Summit in Washington, D.C. The summit’s focus was to help attendees better understand the finer points of U.S....